CoChat

The interaction of antidepressant drugs with central and peripheral (enteric) 5‐HT3 and 5‐HT4 receptors

Open access
Lucchelli, A., Santagostino‐Barbone, M.G., Barbieri, A., Candura, S.M., Tonini, M. · 1995 · British Journal of Pharmacology
Cited by 49

The DOI matches its Crossref record.

Abstract

A combined study of receptor binding in central neuronal cell membranes and functional responses in isolated segments of guinea‐pig small intestine allowed characterization of the interaction of four antidepressant drugs with central and peripheral 5‐HT 3 and 5‐HT 4 receptors. Clomipramine, paroxetine and fluoxetine inhibited [3 H]‐DAU 6215 binding to 5‐HT 3 recognition sites in NG 108‐15 cells with IC 50 values in the range 1.3–4 μ m. Litoxetine had an IC 50 of 0.3 μ m. The specific binding of [3 H]‐GR 113808 to 5‐HT 4 recognition sites in pig striatal membranes was inhibited by all four antidepressants with negligible potency (IC 50 values ≥ 20 μ m). In whole ileal segments, concentration‐response curves to 5‐HT were biphasic, with the high‐ and low‐potency phases involving 5‐HT 4 and 5‐HT 3 receptors, respectively. Curves to 2‐methyl‐5‐hydroxytryptamine (2‐methyl‐5‐HT: a 5‐HT 3 receptor agonist) and 5‐methoxytryptamine (5‐MeOT: a 5‐HT 4 receptor agonist) were monophasic. All antidepressants were used at concentrations lacking anticholinoceptor properties, as demonstrated in both electrically stimulated longitudinal muscle‐myenteric plexus preparations (LMMPs) and in unstimulated LMMPs following addition of acetylcholine (100 n m). Fluoxetine (0.1–1 μ m) and litoxetine (0.3–3 μ m) antagonized both the high‐ and low‐potency phases of the 5‐HT curve. Schild analysis for the low‐potency phase yielded pA 2 estimates of 6.6 ± 0.3 (Schild slope of 1.1) and of 6.6 ± 0.1 (Schild slope of 1.1), respectively. At higher concentrations (3 μ m), fluoxetine markedly inhibited the 5‐HT response maximum. Clomipramine (10–300 n m) inhibited, by a mechanism independent of concentration, both phases of the 5‐HT curve with a reduction of the maximum response. Paroxetine (1 μ m) was ineffective on the high‐potency phase, but caused a rightward shift of the low‐potency phase (p KB: 6.1 ± 0.01). Responses to 2‐methyl‐5‐HT were inhibited by 1 μ m fluoxetine (p KB: 5.4 ± 0.02). Like clomipramine (30 and 100 n m), litoxetine (1 and 3 μ m) produced rightward displacements of 2‐methyl‐5‐HT‐induced contractions, which were virtually independent of antidepressant concentration (p KB values: 6.0 ± 0.02 and 5.5 ± 0.01, respectively). At higher concentrations, fluoxetine (3 μ m) and clomipramine (300 n m) markedly reduced the 2‐methyl‐5‐HT response maximum. Paroxetine (1 μ m) was ineffective. Responses to 5‐MeOT were shifted to the right by fluoxetine (0.1–1 μ m) and litoxetine (1 and 3 μ m) in a concentration‐dependent manner. At higher concentrations, fluoxetine (3 μ m) markedly reduced the 5‐MeOT response maximum, an effect also observed with 100 and 300 n m clomipramine. Paroxetine (1 μ m) was ineffective. In unstimulated LMMPs, the excitatory effects evoked by 5‐HT, 2‐methyl‐5‐HT and 5‐MeOT and the antagonism produced by 300 n m clomipramine were comparable to those obtained in whole ileal segments. This suggests that 5‐HT contained in the mucosa of whole preparations does not interfere with agonist‐induced contractile responses and with the inhibitory effect of antidepressant drugs. In conclusion, our results show that clomipramine, fluoxetine, paroxetine and litoxetine possess low to moderate potency/affinity at both central and peripheral (enteric) 5‐HT 3 receptors. In contrast, all four antidepressants are virtually ineffective at central 5‐HT 4 receptors. Inhibition of 5‐HT 4 receptor‐mediated ileal contractions by fluoxetine, litoxetine and clomipramine may result from allosteric antagonism or, more likely, from post‐receptor blockade of second messenger generation. The interaction of antidepressants with central and peripheral 5‐HT 3 and 5‐HT 4 receptors may be relevant for both potential therapeutic action and adverse effects at gastrointestinal level.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1995.tb13307.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 49

Metadata

Authors
Lucchelli, A., Santagostino‐Barbone, M. G., Barbieri, A., Candura, S. M., & Tonini, M.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1995-03
Volume
114
Issue
5
Pages
1017-1025
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2101771972
Cited by
49
References
0
FWCI
1.27
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The interaction of antidepressant drugs with central and peripheral (enteric) 5‐HT3 and 5‐HT4 receptors. https://app.cochat.ai/papers/10.1111/j.1476-5381.1995.tb13307.x
The paper
Lucchelli, A., Santagostino‐Barbone, M. G., Barbieri, A., Candura, S. M., & Tonini, M. (1995). The interaction of antidepressant drugs with central and peripheral (enteric) 5‐HT3 and 5‐HT4 receptors. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1995.tb13307.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.